Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Address
7707 GATEWAY BLVD., SUITE 140
NEWARK, CA 94560-1160
Founded
2006
Number of Employees
112
Website
http://www.protagonist-inc.com
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)